Concepedia

Emily Heikamp

EH

Statistics

Publications

12

Citations

2.7K

H-Index

11

Active since

2007

Affiliations

Johns Hopkins Medicine(Current)

Johns Hopkins University

Memorial Sloan Kettering Cancer Center

Cancer Research UK

Dana-Farber Cancer Institute

Emily Heikamp is an author at Johns Hopkins Medicine specializing in molecular biology, life sciences, and oncology.

ORCID

Publications per year

2007–2025

12

Publications

12

The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2

Greg M. Delgoffe, Kristen Pollizzi, Adam T. Waickman et al. · Nature Immunology · 2011 · 1.1K citations · Full text

, , +16

New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes

Helen Sheldon, Emily Heikamp, Helen Turley et al. · Blood · 2010 · 404 citations · Full text

, , +14

Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization

Daniel J. Nolan, Alessia Ciarrocchi, Albert S. Mellick et al. · Genes & Development · 2007 · 394 citations · Full text

, , +15

Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth <i>In vivo</i>

Jiliang Li, Richard C.A. Sainson, Wen Shi et al. · Cancer Research · 2007 · 297 citations · Full text

, , +17

The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex

Emily Heikamp, Chirag H. Patel, Sam Collins et al. · Nature Immunology · 2014 · 195 citations · Full text

, , +10

1–5 of 12